SGP compared with ALMR: revenue, margins and what each company keeps, and the suppliers and customers both name

SGPSpyGlass Pharma, Inc.

Mkt capRevenueRevenue

ALMRAlamar Biosciences, Inc.

Mkt capRevenueRevenue

Compare

SGPSpyGlass Pharma, Inc.

ALMRAlamar Biosciences, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

SGP1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+2.26%—

ALMR1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+30.65%—

= impliedSGP realized, solidALMR realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

SGPSpyGlass Pharma, Inc.

32.97· pre 32.97· delayed

Mkt cap$1.1BRevenue—

ALMRAlamar Biosciences, Inc.

28.91· pre 29.10· delayed

Pre-marketNov 2 '26delayed

Mkt cap$1.8BRevenue$29MQ2 FY26

Compare

Pre-marketNov 2 '26delayed

SGPSpyGlass Pharma, Inc.

ALMRAlamar Biosciences, Inc.

32.97pre 32.97delayed

Price

28.91pre 29.10delayed

$1.1B

Mkt cap

$1.8B

—

Revenue

$29MQ2 FY26

SGP32.97vsALMR28.91Pre-marketNov 2 '26delayed